首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >The medtronic melody? transcatheter pulmonary valve implanted at 24-mm diameter - It works
【24h】

The medtronic melody? transcatheter pulmonary valve implanted at 24-mm diameter - It works

机译:美敦力的旋律?经导管植入直径为24 mm的肺动脉瓣-工作

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives We report the Melody valve implanted and/or expanded to 24-mm diameter. Background The Medtronic Melody valve has been implanted up to 22 mm in the pulmonary position for over a decade. Methods A retrospective chart review was performed on 82 patients who underwent Melody valve implant. Technical implant method, pre- and postimplant echocardiographic findings, and initial follow-up were reviewed. Results Between 04/2008 and 12/2011, 13 Melody valves were successfully implanted in 11 patients, median age 35 years (range 16-61 years), in the pulmonary (bioprosthetic valve, right ventricle to pulmonary artery conduit, native valve) position (n = 9), tricuspid position (bioprosthetic valve n = 3), and aortic position (bioprosthetic valve n = 1). Ten valves were delivered on a 24-mm balloon in balloon catheter and three were implanted using a 22-mm Ensemble balloon delivery system, followed by postdilation using a 24-mm × 2-cm Atlas balloon catheter. Postimplant, the median peak systolic gradient across the pulmonary valve was 7 mm Hg and median gradient across the tricuspid valve was 3 mm Hg. There was no change in gradient across the Melody valve in the aortic position where valve prosthesis-patient mismatch was present. Postimplant intracardiac echocardiography demonstrated none or mild valve regurgitation. No more than mild regurgitation was noted at a median follow-up of 9.5 months. Conclusions The Melody valve can be implanted at 24 mm in the stenotic/regurgitant bioprosthetic pulmonary, tricuspid, and aortic valve, dysfunctional right ventricle to pulmonary artery conduit, and the native right ventricular outflow tract, whereas the valve remains competent with only mild regurgitation.
机译:目标我们报道了Melody瓣膜植入和/或扩大到24毫米直径。背景技术Medtronic Melody瓣膜已在肺部位置植入多达22 mm,已有十多年的历史。方法对82例行Melody瓣膜植入术的患者进行回顾性图表回顾。回顾了技术植入方法,植入前和植入后超声心动图检查结果以及初步随访情况。结果04/2008年至12/2011年间,在11位患者中位年龄35岁(范围16-61岁)的肺部(生物人工瓣膜,右心室至肺动脉导管,天然瓣膜)位置成功植入了13枚Melody瓣膜(n = 9),三尖瓣位置(生物人工瓣膜n = 3)和主动脉位置(生物人工瓣膜n = 1)。将十个瓣膜递送到球囊导管中的24毫米球囊中,并使用22毫米Ensemble球囊递送系统植入三个瓣膜,然后使用24毫米×2厘米Atlas球囊导管进行后扩张。植入后,整个肺动脉瓣的中位收缩压峰值为7 mm Hg,三尖瓣细胞的中位收缩压值为3 mm Hg。在存在瓣膜假体-患者不匹配的主动脉位置,整个Melody瓣膜的梯度没有变化。植入后心脏内超声心动图显示无瓣膜反流或轻度瓣膜反流。在中位随访9.5个月时,仅观察到轻度反流。结论Melody瓣膜可植入狭窄/反流的生物假体肺,三尖瓣和主动脉瓣,功能异常的右心室至肺动脉导管和天然右心室流出道的距离为24 mm,而该瓣膜仅能进行轻度的反流。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号